Reduced heparan sulfate levels in cerebrospinal fluid reflect brain neuron correction in Sanfilippo B mice
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci195268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Steven Q Le und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Heparan Sulfate, Mucopolysaccharidosis III, Neurons, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institute of Allergy and Infectious Diseases
- Hope Center for Neurological Disorders
Zitieren
APA
Le, S. Q., Sorensen, A., Sukupolvi, S., Jewhurst, G., Austin, G., Doray, B., Cooper, J. D., & Dickson, P. I. (2025). Reduced heparan sulfate levels in cerebrospinal fluid reflect brain neuron correction in Sanfilippo B mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci195268
Vancouver
Le SQ, Sorensen A, Sukupolvi S, Jewhurst G, Austin G, Doray B, et al. Reduced heparan sulfate levels in cerebrospinal fluid reflect brain neuron correction in Sanfilippo B mice. Journal of Clinical Investigation. 2025. doi:10.1172/jci195268
BibTeX
@article{Le2025,
author = {Le, Steven Q and Sorensen, Alexander and Sukupolvi, Soila and Jewhurst, Gianna and Austin, Grant and Doray, Balraj and Cooper, Jonathan D and Dickson, Patricia I},
title = {Reduced heparan sulfate levels in cerebrospinal fluid reflect brain neuron correction in Sanfilippo B mice},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci195268}
}
EUVIMED